510(k) K120986
K120986 is an FDA 510(k) premarket notification submitted by Focus Diagnostics, Inc. for the device "STRATIFY JCV DXSELECT". The FDA issued a decision of Substantially Equivalent on Aug 16, 2012. The device falls under product code OYP (Anti-Jcv Antibody Detection Assay), a Class II device regulated under 21 CFR 866.3336. Focus Diagnostics, Inc. has 17 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 16, 2012
- Date Received
- Apr 2, 2012
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Anti-Jcv Antibody Detection Assay
- Device Class
- Class II
- Regulation Number
- 866.3336
- Review Panel
- MI
- Submission Type
- 510(k)
The anti-jcv antibody detection assay is intended for the detection of antibodies to the john cunningham virus (jcv) in serum or plasma samples from multiple sclerosis (ms) and crohn's disease (cd) patients receiving immunomodulatory therapies.
Need the full FDA record for Focus Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.